Products in Development
Learn about our products and how they work
The company is focused on the development of two unique spinal cord neuromodulator systems (electric stimulation devices) sharing platform technology to address a significant unmet clinical need – restoring function and movement in patients with paralysis.
The first product is a non-invasive external (transcutaneous) system, which we believe to be a Class II non-significant risk device (FDA DeNovo submission), for those individuals with partial to complete paralysis.
The second system is an implantable (Epidural) system used to optimally treat individuals with severe motor paralysis who do not respond to our transcutaneous device.
Each system is composed of complementary electrodes plus a pulse generator containing proprietary circuitry and algorithms with our discovered formula for reactivating neural circuits. The systems facilitate customized programming and independent control of multiple stimulation sites.
Both a diagnostic tool and treatment device
Therapeutic stimulation is delivered through hydrogel electrodes
Hand held portable device for home use
Integrates with a physician base station
Wireless technology for transmitting and receiving data
Variable control of stimulation parameters
(frequency, amplitude, pulse duration, etc.)
Customizable to each patients needs
Regulated by a wireless hand held controller
Wireless network capability for transmitting and receiving data
Rechargeable Lithium ion battery